Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure.
about
Managing mitral regurgitation: focus on the MitraClip deviceCurrent challenges in interventional mitral valve treatmentMitral Valve Clip for Treatment of Mitral Regurgitation: An Evidence-Based AnalysisThe future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis.One-year outcome of percutaneous mitral valve repair in patients with severe symptomatic mitral valve regurgitation.MitraClip for severe symptomatic mitral regurgitation in patients at high surgical risk: a comprehensive systematic review.Preoperative evaluation before MitraClip®: present and future perspective.Role of percutaneous mitral valve repair in the contemporary management of mitral regurgitation.Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic review.Mitral regurgitation. Timing of surgery or interventional treatment.Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation.Quality of life after mitral valve intervention.Predictors for long-term survival after transcatheter edge-to-edge mitral valve repair.Functional mitral regurgitation and left ventricular systolic dysfunction in the recent era of cardiovascular clinical practice, an observational cohort study.Influence of experience on procedure steps, safety, and functional results in edge to edge mitral valve repair-a single center study.Multimodality imaging assessment of mitral valve anatomy in planning for mitral valve repair in secondary mitral regurgitation.Cardiovascular medicine heart failure (CVM-HF) index as prognostic model for candidates to MitraClip therapy.Safety and efficacy of MitraClip™ therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry.Long-term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge-to-edge mitral valve repair.Effectiveness of MitraClip therapy in patients with refractory heart failure.Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.Influence of non-cardiac comorbidities on outcome after percutaneous mitral valve repair: results from the German transcatheter mitral valve interventions (TRAMI) registry.Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: a single-centre experience.Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure.Three-dimensional transoesophageal echocardiography is crucial for valid assessment of mitral valve leaflet morphology in severe mitral regurgitation prior to interventional repair.The EJHF last Editor's legacy: how can a high impact factor be built?Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip.Percutaneous mitral valve repair.
P2860
Q26750699-F5CD6B1F-1967-4CE9-ACB6-82DD2FD42563Q26778723-82F90DAE-DBB9-49EC-A770-254CC65C5EBAQ26784373-14FCC5FA-92A6-430D-83B6-32C843C24683Q26860834-8741F40D-69B6-4CF7-869D-BE85E26A85C9Q35774678-3385CE5C-3720-43D4-930C-5FAC9B9086FEQ36394080-E4D2B4C3-1DFF-43EB-9F47-51EF8E98A1B7Q37597746-3D6C55B4-0BD6-4B5F-A2AC-4F7A5D115D1BQ38218225-178C75DB-40B0-4A14-9CCC-F39C353F3296Q38286288-D7A24A8A-EB56-472C-8D71-45C9EEE3F804Q38534993-BBCE456D-9FE9-424B-B27D-671F204EC1EFQ38635629-B51FEFC7-D53A-45C2-AB5B-FA6841196527Q38667322-AA065B6E-A6BF-4399-8A90-B88006C080DCQ38724951-8B0FD0D4-97C0-4A14-BE12-6D67DFC30573Q38802006-CEF5C20E-1AB4-4A1E-A5FF-4F7D93963AF2Q38859347-70149327-9B9D-4A9B-A0C1-0CD31FDC9BD7Q39138710-D36D2F34-27D3-4A41-A708-7362C64794F7Q39369909-1AED9D25-EB81-48DC-8749-1D299D6A2443Q39456015-75E42A53-7DC6-422D-8B86-4C1334FAD0D2Q40180711-059CC995-337F-4424-8DB7-C2B0B7A58E60Q40498485-3E0C00D8-4F2F-4407-AC9E-9E50B9BD7CD0Q41096300-B477D9FF-5E44-4F27-99E4-3AA9B696321DQ41416657-14A46AC4-5ABD-4431-B430-B23B33122E3BQ41487848-FB307E56-691B-4664-B243-3D186A08F8A7Q41709982-A3E54540-9434-403E-82DB-21B885A790EEQ45301848-5F09E978-FC69-4FBC-8FC6-FA9121E5A46FQ46150031-A52A4EA1-19AC-4321-BAA5-C3028A41038EQ47864364-74AE6232-092D-4428-A689-323F3E843BA9Q50584662-22FB63E7-D940-456D-B07B-F97F63364A20Q53152246-4095DA9E-C280-4825-A986-EF51F4F4F2B0Q53664261-EE4FF625-F488-499A-9D63-536ABDB552F0
P2860
Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Patient selection criteria and ...... vere congestive heart failure.
@en
Patient selection criteria and ...... vere congestive heart failure.
@nl
type
label
Patient selection criteria and ...... vere congestive heart failure.
@en
Patient selection criteria and ...... vere congestive heart failure.
@nl
prefLabel
Patient selection criteria and ...... vere congestive heart failure.
@en
Patient selection criteria and ...... vere congestive heart failure.
@nl
P2093
P2860
P356
P1476
Patient selection criteria and ...... vere congestive heart failure.
@en
P2093
Christian Butter
Frank Hölschermann
Jürgen Meyhöfer
Maren Schoepp
Martin Seifert
Michael Neuss
Thomas Schau
P2860
P304
P356
10.1093/EURJHF/HFS214
P577
2013-01-16T00:00:00Z